EUVIMEDEUVIMED entdecken
Crossref

Side-Chain Fluorine Engineering of Vitamin D3 Derivatives for VDR-Silent SREBP Inhibitors

Fumihiro Kawagoe, Sayuri Mototani, Tomofumi Yatsu, Yasushi Takemoto, Yusuke Akagi, Toshie Fujishima, Yoshiki Miyata, Motonari Uesugi, Atsushi Kittaka

Chemical and Pharmaceutical Bulletin · 2025

DOI: 10.1248/cpb.c25-00363 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, 2025. Verfasst von Fumihiro Kawagoe und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan. Hauptthemen laut MEDLINE: Receptors, Calcitriol, Cholecalciferol, Fluorine, Sterol Regulatory Element Binding Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study reports on the structure-activity relationships of side-chain shortened and fluorinated vitamin D3 analogs (5-13), with the goal of developing vitamin D analogs that are silent toward the vitamin D receptor (VDR) while retaining inhibitory activity against sterol regulatory element-binding protein (SREBP). The biological activities of the synthesized fluorinated vitamin D3 analogs were assessed through their effects on the VDR ligand-binding domain (VDRLBD), full-length VDR transcriptional activity, and SREBP transcriptional activity. Among the synthesized analogs, 8, 11, and 13 exhibited notable SREBP inhibitory activity, although their potency was lower than that of the natural vitamin D3 metabolite, 25(OH)D3 (1). Compound 11 emerged as the most effective analog, displaying selective SREBP inhibition with minimal VDR activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, CalcitriolCholecalciferolFluorineSterol Regulatory Element Binding ProteinsStructure-Activity RelationshipHumansMolecular Structure

Stichwörter der Autor:innen

ligand-binding domainshortened side chain fluorinated vitamin D3sterol regulatory element-binding proteinvitamin D receptor

Substanzen

Receptors, CalcitriolCholecalciferolFluorineSterol Regulatory Element Binding Proteins

Autor:innen und Institutionen

  • Faculty of Pharmaceutical Sciences, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan.
  • Department of Radiation Oncology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima 960-1295, Japan.
  • Faculty of Pharmaceutical Sciences, Teikyo Heisei University, 4-21-2 Nakano, Nakano-ku, Tokyo 164-8530, Japan.
  • Institute for Chemical Research and Institute for Integrated Cell-Material Sciences (WPI-iCeMS), Kyoto University, Uji, Kyoto 611-0011, Japan.
  • School of Pharmacy, Fudan University, Shanghai 201203, China.
  • Faculty of Science and Engineering, Waseda University, 3-4-1 Ohkubo, Shinjuku-ku, Tokyo 169-8555, Japan.

Zitieren

APA

Kawagoe, F., Mototani, S., Yatsu, T., Takemoto, Y., Akagi, Y., Fujishima, T., Miyata, Y., Uesugi, M., & Kittaka, A. (2025). Side-Chain Fluorine Engineering of Vitamin D3 Derivatives for VDR-Silent SREBP Inhibitors. Chemical and Pharmaceutical Bulletin. https://doi.org/10.1248/cpb.c25-00363

Vancouver

Kawagoe F, Mototani S, Yatsu T, Takemoto Y, Akagi Y, Fujishima T, et al. Side-Chain Fluorine Engineering of Vitamin D3 Derivatives for VDR-Silent SREBP Inhibitors. Chemical and Pharmaceutical Bulletin. 2025. doi:10.1248/cpb.c25-00363

BibTeX
@article{Kawagoe2025,
  author = {Kawagoe, Fumihiro and Mototani, Sayuri and Yatsu, Tomofumi and Takemoto, Yasushi and Akagi, Yusuke and Fujishima, Toshie and Miyata, Yoshiki and Uesugi, Motonari and Kittaka, Atsushi},
  title = {Side-Chain Fluorine Engineering of Vitamin D3 Derivatives for VDR-Silent SREBP Inhibitors},
  journal = {Chemical and Pharmaceutical Bulletin},
  year = {2025},
  doi = {10.1248/cpb.c25-00363}
}
Kostenlos starten →